Filing Details

Accession Number:
0000950170-24-093883
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-08 16:05:16
Reporting Period:
2024-08-07
Accepted Time:
2024-08-08 16:05:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Revvity Inc. RVTY Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1440132 S Joel Goldberg 940 Winter Street
Waltham MA 02451-1457
Please See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-07 964 $116.06 35,936 No 4 S Direct
Common Stock Disposition 2024-08-07 703 $116.86 35,233 No 4 S Direct
Common Stock Disposition 2024-08-07 785 $118.80 34,448 No 4 S Direct
Common Stock Disposition 2024-08-07 1,048 $119.48 33,400 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 63,709 Indirect By Goldberg Irrevocable 2021 Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 7, 2024.
  2. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.38 to $116.29. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.48 to $117.25. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  4. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $118.27 to $119.21. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  5. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $119.30 to $120.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  6. Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.